Abbreviations; Acknowledgements; 1 Bioprospecting for Drug Research: An overview; 2 Drug R & D and the structure of the industry; 3 International policy dimensions of bioprospecting; 4 Transaction costs and their impact on the market forbioprospecting; 5 Intellectual property rights on traditional medicinal knowledge:A process oriented perspective; 6 The scope of the right to regulate access; 7 Conclusions and recommendations; Appendix I; Appendix II; Appendix III; References; Index
Summary
Bioprospecting, or the search for useful biochemical compounds and genes in nature, has been the focus of international negotiations for more than a decade, yet the debate on the terms for access to genetic resources, traditional knowledge and benefit-sharing is far from settled. This book examines the optimal property rights structures and institutional mechanisms for regulating bioprospecting for drug research. Focusing on the economics of contracts, it shows that the rights exchanged are complementary at each stage of drug discovery and the development of genetic resources. Defining and enfor
Bibliography
Includes bibliographical references (pages 251-267) and index
